Ad-hoc Release pursuant to Section 15 of the German Securities Trading Act (Wertpapierhandelsgesetz)
12/16/2010
Ad-hoc: Biofrontera received official review of its drug approval dossier for BF-200 ALA
9/3/2010
Ad-hoc: Biofrontera AG closes placement of capital increase
9/1/2010
Ad-hoc: Biofrontera files European drug application for BF-200 ALA
8/4/2010
Ad-hoc: Biofrontera AG decides on capital increase
6/16/2010
Ad-hoc: Consolidation of Biofrontera shares under a single ISIN
6/10/2010
Ad-hoc: Biofrontera AG closes placement of capital increase
6/7/2010
Ad-hoc: Biofrontera AG decides capital increase
